Search research articles
Contact Us
Filters
Showing results (41-50 of 53) with videos related to
Page
of 6
Sort By:
Cellular Immunology
|
November 1, 1990
Mechanisms of pertussis toxin inhibition of lymphocyte-HEV interactions. I. Analysis of lymphocyte homing receptor-mediated binding mechanisms
P D Steen, E R Ashwood, K Huang, et al.
Transplantation
|
September 12, 1998
Relative importance of cytotoxic T lymphocytes and nitric oxide-dependent cytotoxicity in contractile dysfunction of rejecting murine cardiac allografts
S G Menon, L Zhao, S Xu, et al.
AJR. American Journal of Roentgenology
|
October 6, 1997
Identification of interleukin-2-induced complete response in metastatic renal cell carcinoma by FDG PET despite radiographic evidence suggesting persistent tumor
D A Mankoff, J A Thompson, P Gold, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
October 1, 1995
Effectiveness and toxicity of protracted nitric oxide synthesis inhibition during IL-2 treatment of mice
W E Samlowski, C Y Yim, J R McGregor, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 19, 2000
Soluble biodegradable polymer-based cytokine gene delivery for cancer treatment
A Maheshwari, R I Mahato, J McGregor, et al.
Investigational New Drugs
|
September 20, 2001
Evaluation of gemcitabine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Southwest Oncology Group phase II study
W E Samlowski, H Gundacker, J P Kuebler, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 1, 1997
Acute dyslipoproteinemia induced by interleukin-2: lecithin:cholesteryl acyltransferase, lipoprotein lipase, and hepatic lipase deficiencies
L K Kwong, D N Ridinger, M Bandhauer, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 1, 1995
Nitric oxide synthesis contributes to IL-2-induced antitumor responses against intraperitoneal Meth A tumor
C Y Yim, J R McGregor, O D Kwon, et al.
Investigational New Drugs
|
June 9, 1999
Evaluation of Tomudex in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Southwest Oncology Group study
W E Samlowski, D Lew, P J Kuebler, et al.
Cellular Immunology
|
September 23, 1998
Receptor-mediated activation of murine peritoneal macrophages by antithrombin III acts as a costimulatory signal for nitric oxide synthesis
J Y Kwak, S Y Park, M K Han, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 53) with videos related to
Sort By:
Page
of 6
Cellular Immunology
|
November 1, 1990
Mechanisms of pertussis toxin inhibition of lymphocyte-HEV interactions. I. Analysis of lymphocyte homing receptor-mediated binding mechanisms
P D Steen, E R Ashwood, K Huang, et al.
Transplantation
|
September 12, 1998
Relative importance of cytotoxic T lymphocytes and nitric oxide-dependent cytotoxicity in contractile dysfunction of rejecting murine cardiac allografts
S G Menon, L Zhao, S Xu, et al.
AJR. American Journal of Roentgenology
|
October 6, 1997
Identification of interleukin-2-induced complete response in metastatic renal cell carcinoma by FDG PET despite radiographic evidence suggesting persistent tumor
D A Mankoff, J A Thompson, P Gold, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
October 1, 1995
Effectiveness and toxicity of protracted nitric oxide synthesis inhibition during IL-2 treatment of mice
W E Samlowski, C Y Yim, J R McGregor, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 19, 2000
Soluble biodegradable polymer-based cytokine gene delivery for cancer treatment
A Maheshwari, R I Mahato, J McGregor, et al.
Investigational New Drugs
|
September 20, 2001
Evaluation of gemcitabine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Southwest Oncology Group phase II study
W E Samlowski, H Gundacker, J P Kuebler, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 1, 1997
Acute dyslipoproteinemia induced by interleukin-2: lecithin:cholesteryl acyltransferase, lipoprotein lipase, and hepatic lipase deficiencies
L K Kwong, D N Ridinger, M Bandhauer, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 1, 1995
Nitric oxide synthesis contributes to IL-2-induced antitumor responses against intraperitoneal Meth A tumor
C Y Yim, J R McGregor, O D Kwon, et al.
Investigational New Drugs
|
June 9, 1999
Evaluation of Tomudex in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Southwest Oncology Group study
W E Samlowski, D Lew, P J Kuebler, et al.
Cellular Immunology
|
September 23, 1998
Receptor-mediated activation of murine peritoneal macrophages by antithrombin III acts as a costimulatory signal for nitric oxide synthesis
J Y Kwak, S Y Park, M K Han, et al.
Page
of 6